Which GERD syrup works best? new study pits alginate against sucralfate
NCT ID NCT07310927
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether alginate (Gaviscon) or sucralfate (Ulsanic) provides better symptom relief for people with GERD who are already taking acid-reducing medication (PPIs). 140 adults with frequent severe heartburn took one of the two syrups before meals. Researchers measured symptom severity and quality of life using questionnaires. The goal was to see which add-on treatment works best and is easier to tolerate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Alginate (Gaviscon) and Sucralfate (Ulsanic)
What this could lead to
If this works, it could show that adding alginate or sucralfate to standard PPI therapy provides better symptom relief for people with GERD.
What could go wrong
This is a completed Phase 2/3 trial with 140 participants, but it compares two existing drugs, so it is not a breakthrough. Results may not apply to everyone with GERD, especially those with certain health conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cmh Lahore
Lahore, Punjab Province, 54180, Pakistan